International standards for stem cell treatment of neurological disorders have not yet been established. In particular, specific quantitative methods have not yet been adopted to assess the effectiveness of stem cell treatment. The aim of this study is to evaluate the functional changes detectable by conventional neurophysiologic methods in an injured spinal cord during stem cell therapy. Twenty adult patients with chronic spinal cord injury at C4-C8 level were examined by somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs) methods, the first time prior to the treatment and then regularly during its course (1-4 years). The treatment consisted of repeated intrathecal transplantations of autologous hematopoietic stem cells. After at least 1 year of treatment, four effects were detected: 1) restoration of the initially absent short-latency SEP (three patients); 2. N20P23 interpeak amplitude increase in SEP elicited by median nerve stimulation (four patients); 3) P38 latency reduction in SEP elicited by tibial nerve stimulation (two patients); 4) appearance of MEP (three patients). The nonidentical effects of stem cell transplantation in different patients presumably reflect the variety of the regeneration processes in different pathways of the spinal cord, depending on the extent and nature of lesion of the spinal cord pathways in different patients. The local effects of stem cell treatment at the cervical level were evaluated by median SEP and wrist muscle MEP demonstrate the ability of stem cells to spread within the spinal cord at least from lumbar to the cervical level, home there, and participate in the neurorestoration processes.
INTRODUCTION
spinal cord pathways, respectively (3, 5, 6) . Compared with other available methods, SEPs and MEPs are truly objective (i.e., they do not require the patient's report or The prospects of stem cell transplantation for the treatment of various neurological disorders have been voluntary effort to contract the muscles). Compared to clinical examination, neurophysiological methods are intensively studied in the last two decades (12). A number of experiments have demonstrated the promising more precise and give important additional information concerning the processes underlying the recovery. For potential of stem cells in spinal cord injury (SCI) treatment (10, 11, 13 ). Yet the benefit of cell therapy in SCI example, the nervous impulse conduction velocity can be estimated only by these methods. is debatable. The mechanisms of stem cell action within the damaged spinal cord remain unknown. At present, Previous studies have shown the positive effects of stem cell transplantation in SCI patients by the measure-only a few clinical trials have been conducted. Some results were confirmed by quantitative methods, ment of SEPs and MEPs. The appearance of the initially absent response and its amplitude increase were reported although such evaluation was unsystematic.
A limited number of quantitative methods are avail- (14) . However, most of the described cases were attributed to the acute or subacute (within 3 months) stage able to assess the function of spinal cord pathways. Somatosensory evoked potentials (SEPs) and motor of SCI. In such cases the stem cells' effect cannot be differentiated from spontaneous recovery. Some cases of evoked potentials (MEPs) enable direct estimation of the nervous impulse conduction via afferent and efferent SEP restoration after stem cell transfusions in chronic SCI patients have also been previously reported (13). filgastrim, Neupogen) administered for 4 days twice a day at a dosage of 2.5-6.8 µg/kg (mean 4.3 µg/kg) was However, the results are not conclusive because the observed changes may reflect small fluctuations in con-used as a colony-stimulating factor. The peripheral hematopoietic stem cells (PHSCs) were collected on the duction. Valid assessment of such subtle changes requires stability during repeated testing.
fifth day by a standard procedure of leukapheresis using a blood cell separator (COBE Spectra, Gambro BCT, We review the data obtained by regular neurophysiologic examination of 20 chronic SCI patients, who had USA). The amount of all mononuclear cells and CD34 + cells collected in one patient was 15-20 × 10 9 and 56-taken the course of stem cell treatment in our clinic. Intrathecal injections of stem cells were performed with 171 × 10 6 , respectively. The material was divided into 14-20 aliquots, each containing 4-8.5 × 10 6 CD34 + the interval of several months. The transplanted hematopoietic autologous stem cells (CD34 + ) are multipotent cells and 1.3-1.5 × 10 9 leukocytes in the volume of 2 ml. The cryopreservation was performed in sterile con-stem cells able to transform into neuroprotective glia, myelin-producing oligodendrocytes, and astrocytes. ditions using 10% dimethyl sulfoxide (DMSO) and polyglycine. For every patient all material was preserved They are considered to be capable of concentration in an injured area where they participate in neuroregenera-in this way except for one aliquot that was taken for standardization and certification purposes. tive process.
In a recent study of Cristance et al. (4), hematopoietic One aliquot of PHSCs was used per dose. Before transplantation, the material was prepared by defrosting and autologous stem cells were found to be rather effective in the treatment of chronic SCI. These authors report elimination of DMSO and polyglycine using centrifugation with 0.9% saline solution and suspended in ϳ2 ml of recovery of the somatosensory evoked response elicited by tibial nerve stimulation in more than half of the cerebrospinal fluid gathered by spinal tap. The prepared PHSCs were delivered intrathecally to the subarachnoid patients with previously "electrophysiologically complete" (no response) SCI. In our trial "electrophysiologi-space during standard lumbar puncture twice over an 8day period, with an interval of several months (usually cally incomplete" patients were included as well, but the region of interest was limited to cervical cord injury.
3-5 months) before the next two doses. The duration of the course was 1-4 years (usually 1.5-2.5 years). To increase the reliability of the data we used a series of MEP and SEP examinations, repeated on average SEP and MEP Examination every 4-5 months during at least 1 year of follow-up since the beginning of stem cell therapy. The aim of this All SEP and MEP recordings were made and interpreted by the same person. Medtronic keypoint (USA) study is to evaluate and to measure functional changes in an injured spinal cord of patients treated by stem was used to perform the neurophysiologic examination. SEP recordings were performed prior to stem cell ther-cell transplantation.
apy and later with an interval of several months (on MATERIALS AND METHODS average 4-5 months) during the treatment course. The Patients evoked potentials were elicited by rectangular pulse (0.2 ms duration) stimulation delivered unilaterally to the Twenty patients (15 men, 5 women, ranging from 18 to 55 years old, mean age ± SD, 32.41 ± 11.67) with median (wrist level) or tibial (medial malleolus) nerves. The rate of stimulation was 3.3 and 0.47 Hz, respec-chronic complete and incomplete traumatic SCI were enrolled in this study. The time postinjury varied from tively. The intensity was 25 and 50 mA, respectively. SEPs were elicited by right/left median nerve stimula-1 to 9 years (3.39 ± 3.11). The level of injury varied from C4 to C8. The control group included 10 patients tion (median SEP) or tibial stimulation (tibial SEP). Median SEP was recorded from surface scalp electrodes matched by sex and age and type of SCI. Before being admitted to our clinic all patients had passed the course placed 10 mm posterior to C3/C4 according to international 10-20% system (7). Tibial SEP was recorded of standard therapy and rehabilitation with or without any effect, but exhibited no progress during several from surface scalp electrodes placed 10 mm posterior to Cz. Fz was the reference electrode. The test was per-months before the beginning of stem cell therapy. None of them underwent surgical treatment just before or dur-formed for every patient. The epoch of analysis was 200 ms for median SEP and 500 ms for tibial SEP. Two ing the course of stem cell therapy. During the period of observation they did not change principally their usual averaged series (at least 300 stimulations each) were obtained during every test. All the SEP recordings were physical rehabilitation courses. The study was approved by the local ethics committee. All patients gave carefully inspected and those containing visually detected artifacts [e.g., electromyographic (EMG) arti-informed written consent.
Autologous stem cell mobilization and harvesting fact] were excluded from further analysis. The assessment of the stability of SEP dynamics was based on were performed by standard techniques. Recombinant human granulocyte-colony stimulating factor (G-CSF;
visual expert analysis of series of the recordings.
MEPs were elicited by 100% transcranial magnetic Patients With Initially Absent Short-Latency (P38N45) Tibial SEP stimulation using Schwarzer mags 2 magnetic stimulator (Germany) of primary motor cortex and recorded in con-In right foot tibial SEP of 15 patients' P38N45 was tralateral abductor digiti minimi (ADM) muscle. MEPs initially absent; restoration of short-latency SEP was were not performed if the response of ADM was absent noted in two patients after stem cell therapy. In left foot during ulnar nerve stimulation. Also, some patients tibial SEP of 16 patients' P38N45 was initially absent; refused to have transcranial magnetic stimulation.
restoration of short-latency SEP was noted in two Finally, 15 patients were examined by MEP. This test patients after 1-1.5 years of stem cell therapy. was made prior to the treatment and every 4-5 months
One patient demonstrated bilateral tibial SEP restoraduring it. Cases were grouped according to their prior to tion (Fig. 1) and one had tibial SEP plus medial SEP treatment MEP examination results: group I, MEP restoration on the same (left) side. absence; group II, nonstructured MEP of unstable form
Conventional SEP pattern analysis includes only in which principle components could not be identified;
short-latency SEP assessment, while so-called middlegroup III, MEP of stable form in a sequence of five latency and long-latency potentials are usually neglected stimulations.
[except for the nociception studies (13)]. Nevertheless, it must be noted that in all studied SEP patterns these RESULTS potentials were always found in the recordings preceding the restoration of short-latency SEP. In some Patients With Initially Absent patients only restoration of middle-and long-latency Median SEP SEP was found. In right-hand median SEP of two patients' N20P23 was initially absent; restoration of short-latency SEP Patients With Initially Present Short-Latency (N20P23) was noted in none of the patients after stem cell therapy.
Median SEP In left-hand median SEP of three patients' N20P23 was initially absent; restoration of short-latency SEP was
The latency value of N20 was within the normal range in all the examined patients. During the course noted in one patient after 1 year of stem cell therapy. of therapy no pathologic increase of latency values was tibial SEP). The mean P38 latency reduction was 1.2 ± 2.8 ms/year. observed in any of the analyzed SEP patterns.
A clear interpeak N20P23 amplitude increase (Fig. 2) No stable changes in P38N45 interpeak amplitude were found. Any stable changes in SEP pattern of the was detected in some patients: bilateral in one patient and unilateral in three patients (all in left median SEP). control group were not detected. This effect was constant only in SEP patterns initially MEP Restoration characterized as low amplitude. In patients, who initially After 1-1.5 years of treatment the following progress had an N20P23 of abnormally low amplitude (less than was observed in right ADM: MEP appeared in one of 2 µV), mean amplitude increase was 0.22 ± 0.70 µV/ three patients of group I (Fig. 4) tions with the interval of several months revealed the After 1-1.5 years of therapy the gradual reduction (from apparent temporal instability of MEP characteristics. test to test) of P38 latency was evident (Fig. 3) 
in one
Any stable MEP changes in the control group were patient bilaterally and in one patient unilaterally (in right not detected.
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DISCUSSION potential of peripheral nerve reflecting the axonal loss was typical for SCI patients during cell regenerative treatment as well. That the effects of stem cell transplantation vary with patients presumably reflect the variety of the regenera-It is important that the median SEP amplitude increase was noted predominantly in patients with an tion processes in different pathways of the spinal cord, depending on the extent and nature of the lesion of the initially low amplitude SEP. This observation demonstrates that the true restorative effect was due to the stem spinal cord pathways in different patients.
One of the observed effects-the increase of short-cells, but not the general SEP amplitude enhancement. We consider that short-latency SEP restoration is simply latency median SEP amplitude-must indicate the enlargement of the amount of the conducting axons.
the special case of the amplitude increase effect-the increase from zero level. The same is true not only for Changes in peripheral axon can hardly cause the increase of SEP amplitude. On the contrary, the slow median SEP and tibial SEP restoration, but also for MEP restoration. axonal loss in peripheral nerves often takes place in SCI patients (9). The peripheral axon and the body of the Another effect is the reduction of the SEP latency, which was pronounced mainly in tibial SEP. The latency peripheral sensory neuron are located outside of the CNS where the stem cells are delivered. We performed value of the early median SEP was initially within the normal limits because median SEP (if present) was pro-electroneurography on the sural nerve of 48 patients before and after 1 year of stem cell therapy. The results duced by the impulses conducted through the intact fibers corresponding to the spinal segments located (unpublished data) showed that the decrease of action The stem cell treatment was started 1 year after injury. Latency of SEP components is given in milliseconds. Short-latency components in each curve are well identified (so called anterior cord syndrome is characterized by preservation of dorsal columns). Note the reduction of P38 latency during stem cell therapy from 54 to 46 ms in 17 months. higher than the injury. In tibial SEP the initial recordings
We have not detected the universal effect of stem cell transplantation in the spinal cord; each of the detected revealed the abnormal latency increase in most of the cases (in four of five patients). After 1 year of treatment effects was not frequent in the group of patients. We suppose that the variety of the revealed effects can be in some patients the reduction of latency constituted several milliseconds and showed a stable trend with time. explained by differences in the initial state (axonal loss, variants of demyelination) of spinal pathways: anterolat-The conduction time, which reflects the conduction velocity, is considered to be a sensitive electrophysio-eral cortico-spinal tract (tested by MEP) and dorsal columns pathway of proprioception (tested by SEP). The logical marker of myelin consistency. The remyelination potential of stem cells is well known. Various stem cell observed changes were relatively small in most of the patients. Moreover, the dynamics of SEP parameters populations were shown to myelinate efficiently after transplantation into damaged neural structures (2,12). was often nonlinear. So serial recordings during the long period of observation (to our opinion at least 1 year) The remyelinating potential of bone marrow stem cells was reported by Akiyama et al. (1) . are required to verify the trend. In this sense SEP method is more precise then MEP. Besides, added to Principally, all of the mentioned effects can be explained by a remyelinating process. The extensive clinical assessment of spinal cord functions SEP examination offers important information about pathways of myelin defect can cause the blockage of the impulse propagation. So with myelin restoration the number of proprioception, the function of which is difficult to assess during clinical examination. effectively conducting fibers will increase. This must result in SEP amplitude increase and SEP restoration. On Clinical neurologic assessment before and during the treatment was based on the ASIA scale. We did not the other hand, demyelination usually causes dispersion of conduction velocities in nervous fibers. The dispersion of observe any clinical neurophysiologic correlations. This can be explained by the variety of the detected effects resulting single potentials affects their summation in the compound potential and influences its amplitude. and variety of clinical manifestations of improvement in
